- Home
- PRTS vs IGC Comparison
PRTS vs IGC Comparison
Compare PRTS & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- IGC
- Stock Information
- Founded
- PRTS 1995
- IGC 2005
- Country
- PRTS United States
- IGC United States
- Employees
- PRTS N/A
- IGC N/A
- Industry
- PRTS Auto & Home Supply Stores
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- IGC Health Care
- Exchange
- PRTS Nasdaq
- IGC Nasdaq
- Market Cap
- PRTS 40.0M
- IGC 39.8M
- IPO Year
- PRTS 2007
- IGC N/A
- Fundamental
- Price
- PRTS $0.94
- IGC $0.42
- Analyst Decision
- PRTS Hold
- IGC Strong Buy
- Analyst Count
- PRTS 1
- IGC 2
- Target Price
- PRTS $0.70
- IGC $4.00
- AVG Volume (30 Days)
- PRTS 1.4M
- IGC 1.4M
- Earning Date
- PRTS 10-28-2025
- IGC 08-14-2025
- Dividend Yield
- PRTS N/A
- IGC N/A
- EPS Growth
- PRTS N/A
- IGC N/A
- EPS
- PRTS N/A
- IGC N/A
- Revenue
- PRTS $577,614,000.00
- IGC $1,327,000.00
- Revenue This Year
- PRTS N/A
- IGC $15.26
- Revenue Next Year
- PRTS $2.62
- IGC $3.41
- P/E Ratio
- PRTS N/A
- IGC N/A
- Revenue Growth
- PRTS N/A
- IGC 24.95
- 52 Week Low
- PRTS $0.68
- IGC $0.25
- 52 Week High
- PRTS $1.42
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- PRTS 55.54
- IGC 56.28
- Support Level
- PRTS $0.70
- IGC $0.39
- Resistance Level
- PRTS $1.36
- IGC $0.47
- Average True Range (ATR)
- PRTS 0.11
- IGC 0.04
- MACD
- PRTS 0.03
- IGC 0.00
- Stochastic Oscillator
- PRTS 37.00
- IGC 46.67
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.